 
- 积分
- 68783
- 威望
- 68783
- 包包
- 182946
|
Charter Members
4 b8 p/ {& f& h9 o8 B* |Companies2 T3 U; }1 n' h1 D& P' E# l. X. D$ ]
Aastrom Biosciences
, A$ t; o6 V: w( f+ U2 Y" K$ n& x# zAdvanced BioHealing
8 O: |% i. D8 f/ BAdvanced Cell Technology 5 [9 u/ g( F; e6 @: H' C/ z
Aldagen
7 }1 D/ b. s1 V0 _6 W0 k( [Allosource: h, O0 F6 p; ?' N: N$ N% i
ATCC® The Global Bioresource Center™) y/ u2 |. W) o1 Z" r$ s8 ?
Athersys" x: K& f- V3 M
Beckman Coulter
. O6 x5 L2 t6 H4 Q* G8 ?& b+ pCelgene Cellular Therapeutics
f0 g* U: O6 H& K. SCellerant Therapeutics: m, O4 ~& L, T% i
Corning5 w, P+ X! i; g7 x0 k' P# }; a! U; V
Cytori* `' [$ {& X- g+ R+ d- W# \, h
GE Healthcare
1 A* g$ N5 V9 I$ w, P; ]( oGeron
- R$ _: i& C, e I) J. j7 U3 jFate Therapeutics + |6 O" A A# ~$ ^ k( q
Fisher BioServices % L; w6 s2 o; Y& d- r
International Stem Cell Corporation5 G9 \" j- ~6 O* i9 F
Invetech
5 F* M7 _" n5 n! \6 @/ D- ~) @: `: FiPierian
6 ?" W, O1 z$ b1 K6 x6 YISTO Technologies, Inc.
4 u& k, G' f! {2 d6 aJohnson & Johnson
( y1 _) e4 I1 e4 m5 d$ [6 KMaxCyte
$ X+ d6 W O# ^: e% }Millipore
8 t, c7 Y' k$ S1 F) t! ]+ {2 YOrganovo
* g+ n, |* m$ M/ o! jOrganogenesis. f5 K$ `# |! M( C5 x
Roji Pharma& V9 ~' ]- J$ R1 `+ I
Pervasis Therapeutics Inc.
) ~9 e1 _* L! S! L/ R5 LPfizer Inc
5 x( |# }0 v; I rRegenesis Biomedical
) J. Y& Q. A6 ?+ r( f9 W. ]StemCells Inc.
" V' ~, [" l- G1 w! e0 b3 q0 JTheregen" \' Z4 |, N4 i7 |8 O5 ], z
Tengion
# d! e* ], {. h( {" GTissue Genesis
! Z( I$ T2 z6 y+ k# `8 G6 X. m# O! fViaCyte (formerly Novocell)
( O2 C; a+ x3 K& z& Q2 H3 M2 f( z- GFoundations/Associations
1 I# {" ^/ A! S+ e! X7 X8 nAlliance for Aging Research " b) J; p1 n1 S" k8 o; _
ALS Association
" w( \9 ~# L, F1 ^+ ~" ~7 v; cAssociation of Clinical Research Organizations (ACRO)5 M s1 {5 F* m* C ^5 L8 t
Californians for Cures
' |; M- u: M& C2 ]( _Foundation for Regenerative Medicine (Founding Member)- }7 |9 p6 ?3 D; y4 f# [( O
Genetics Policy Institute6 Z& I" m$ G5 K; Z
Juvenile Diabetes Research Foundation 4 g8 g" j6 ?# h' f0 s
New York Stem Cell Foundation
% Q8 o4 H, ?) _/ D" TPittsburgh Tissue Engineering Initiative # b& W; @5 n9 u" E$ N
Research Institutions
4 h9 `3 f: i5 }7 R9 v; N8 EBurnham Institute for Medical Research
9 ]3 }% O% {. x2 ~# s7 yThe Cleveland Clinic4 y- D5 a' a$ v( ^) b4 I
University of Louisville & Jewish Hospital Cardiovascular Innovation Institute$ E/ b/ @" C5 w# u. W- J
University College London
0 r; s: Z" m2 G: }7 sWake Forest Institute for Regenerative Medicine
$ b0 v9 v' t2 i- C3 }6 fInvestors
) ~& m) C' `% b3 t8 WKleiner, Perkins, Caufield, Byers
0 x8 _0 d3 t- F& ~Proteus Venture Partners' E; {' n/ q+ r, \
Safeguard Scientific 4 z3 |5 r1 R( }& X5 H, }
Toucan Capital |
|